“The greatest mistake in the treatment of diseases is that there are physicians for the body and physicians for the soul, although the two cannot be separated.”
Plato, -400 BC
Dear Clinical Trials Professionals,
Treat the person, not the disease. Plato understood that. After all, clinical trial participants are more than the sum of their medical troubles – each has their own hopes and fears which we should strive to understand to make the clinical trial process more agreeable to all involved (sites and CROs, included). But we already do this, don’t we? Well, according to the statistics, no. Recent data have shown 75 percent of investigators fail to enroll the target number of patients and the average dropout rate for clinical trials stands at 30 percent.
So, why the poor numbers? A key factor is the general population’s misperception of clinical trials. People simply lack a basic understanding of the clinical development process which in turn breeds apprehension – and an uncertain patient is not likely to enroll or follow through with a study.
For an added degree of difficulty, modern clinical trials are becoming more and more complex and require larger numbers of highly-specific patient populations. Competition for patients is fierce. ClinicalTrials.gov alone currently shows more than 29,000 open trials requiring millions of patients globally. To recruit, and just as importantly to keep these patients, we are going to have to do a better job of education and engagement.
There are many wonderful ongoing initiatives aimed at improving perception, but we can do more. We need to educate people about clinical trials before they begin, support them during a study and provide them with guidance once a trial ends. During this conference, leading patient recruitment and retention experts will share their strategies on addressing such challenges, including how:
- Pfizer is launching the first ever randomized virtual clinical trial where patients can participate entirely from home – no matter how far from the investigator site
- Partnership to Accelerate Clinical Electronic Research (PACeR) is creating an economically sustainable, electronic clinical research data network to more efficiently identify potential candidates for clinical research trials and manage their care
- Allos Therapeutics engages patients with rare diseases by developing relationships with advocacy groups, cooperative organizations, and Key Opinion Leaders (KOLs)
You’ll also hear how online screening and Electronic Health Records (EHR) can reduce recruitment time, working with families (not just patients) helps minimize discontinuations and utilizing the right technologies helps to support your patient recruitment strategy.
One topic we’re particularly excited to be covering is the use of social media. Social media is changing the way we communicate and, according to a recent study, the effective utilization of the tool can accelerate research by increasing the number of participants and reducing study costs.
Don’t miss your chance to learn all of this and more! Register today online or call our conference hotline at 888-362-7400 to attend the Advanced Learning Institute’s conference on "Patient Recruitment, Compliance and Retention for Clinical Trials," this October in New York. This is your opportunity to hear from leading clinical trials professionals and organizations that are already using the latest strategies to maximize patient recruitment and engagement.
I look forward to welcoming you to this information-packed event.
Kind regards,
Jeffrey Zucker, Senior Director & Global Head, Feasibility & Patient Recruitment
INC RESEARCH
Conference Chairperson
P.S. Reserve your spot today to learn how you and your clinical trials team can improve your recruitment, compliance and retention efforts. Register 3 people and get the 4th for FREE! Click here for details or call (888) 362-7400. |